Cancer vaccines : sixth international symposium /
محفوظ في:
| مؤلف مشترك: | |
|---|---|
| مؤلفون آخرون: | , , |
| التنسيق: | أعمال مؤتمر كتاب |
| اللغة: | English |
| منشور في: |
Boston, MA :
Published by Blackwell Pub. on behalf of the New York Academy of Sciences,
2009.
|
| سلاسل: | Annals of the New York Academy of Sciences ;
v. 1174. |
| الموضوعات: | |
| الوصول للمادة أونلاين: | Publisher description |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | in00000096339 | ||
| 003 | KWAREICT | ||
| 005 | 20220527123103.0 | ||
| 008 | 120619s2009 maua b 100 0 eng | ||
| 020 | |a 9781573317597 | ||
| 020 | |a 1573317594 | ||
| 035 | |a (Kwareict) u16443 | ||
| 035 | |a (KWAREICT)u16443 | ||
| 040 | |c KwareTech | ||
| 082 | 0 | 4 | |a 616.994061 |b I N T |2 22 |
| 111 | 2 | |a International Cancer Vaccine Symposium |n (6th : |d 2008 : |c New York, N.Y.) | |
| 245 | 1 | 0 | |a Cancer vaccines : |b sixth international symposium / |c edited by Ralph Steinman, Jacques Banchereau, and Olivera J. Finn. |
| 246 | 3 | 0 | |a Cancer vaccines : |b 6th international symposium |
| 246 | 1 | |i Conference title: |a Stages of cancer vaccine development | |
| 260 | |a Boston, MA : |b Published by Blackwell Pub. on behalf of the New York Academy of Sciences, |c 2009. | ||
| 300 | |a vi, 121 p. : |b ill. | ||
| 336 | |a txt |b txt | ||
| 490 | 1 | |a Annals of the New York Academy of Sciences, |x 0077-8923 ; |v v. 1174 | |
| 500 | |a "This volume presents manuscripts stemming from the conference "Sixth International Cancer Vaccine Symposium: Stages of Cancer Vaccine Development," held at the New York Academy of Sciences Conference Center on Oct. 28-30, 2008."--P. v. | ||
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | |a Some scientific and organizational challenges in cancer immunology -- The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells -- Brain tumor immunotherapy with type-1 polarizing strategies -- Harnessing human dendritic cell subsets to design novel vaccines -- Dendritic cell-based vaccines for pancreatic cancer and melanoma -- Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers -- Witch hunt against tumor cells enhanced by dendritic cells -- Harnessing CD1D-restricted t cells toward antitumor immunity in humans -- Immunity against cyclin B1 tumor antigen delays development of spontaneous cyclin B1-positive tumors in p53-/- mice -- Targets of protective tumor immunity -- Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer -- Harnessing dendritic cells to generate cancer vaccines -- Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells -- Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model -- Hematopoietic stem and progenitor cells and the inflammatory response. | |
| 650 | 4 | |a Cancer vaccines |v Congresses. | |
| 650 | 4 | |a Cancer vaccines |v Congresses. | |
| 650 | 4 | |a Krebs (Medizin) |2 idszbz | |
| 650 | 7 | |a Vakzine. |2 idszbz | |
| 700 | 1 | |a Steinman, Ralph M. | |
| 700 | 1 | |a Banchereau, Jacques. | |
| 700 | 1 | |a Finn, Olivera J. | |
| 830 | 0 | |a Annals of the New York Academy of Sciences ; |v v. 1174. | |
| 856 | 4 | 2 | |3 Publisher description |u http://www.loc.gov/catdir/enhancements/fy1011/2010487333-d.html |
| 856 | 4 | 2 | |3 Publisher description |u http://www.loc.gov/catdir/enhancements/fy1011/2010487333-d.html |
| 942 | |2 ddc |c BOOK | ||
| 999 | |c 20507 |d 20507 | ||
| 999 | f | f | |i 73a04119-6c9f-51bd-95d5-9c3cd97871ea |s 8ef13cdb-0d58-52da-9f82-d3c6a8aa2fc5 |